Live Webinar: Decoding Chromatin and Cell Fate with Chemical Precision using CUT&Tag
Thursday, May 7th | 1 PM EDT
Presenter: Dr. Yael David (Memorial Sloan Kettering Cancer Center)
Register NowPresenter: Dr. Yael David (Memorial Sloan Kettering Cancer Center)
Win free CUTANA™ FFPE Transcriptional Activation Profiling for your research
The winner will receive complete end-to-end services: expert project design, on-slide FFPE sample processing, library prep, sequencing, and data delivery - at no cost.
Apply TodayLive Webinar
Decoding Chromatin and Cell Fate with Chemical Precision using CUT&Tag
Thursday, May 7th, 1PM EDT Presenter: Dr. Yael David
Register TodayThursday, May 7th, 1PM EDT Presenter: Dr. Yael David
FFPE Transcriptional Activation Profiling Grant Program
Win free CUTANA™ FFPE Transcriptional Activation Profiling For Your Research
Apply TodayOur mission is to lead the epigenetics field in developing high-quality products and services that accelerate chromatin science to improve and extend human life. In this mission, we hold our core values in high regard: mutual respect, fairness, commitment to excellence, customer success, scientific advancement, effective communication, integrity and teamwork.
Advancing Discovery Through Co-Authored Publications
With decades of experience and active collaborations at the forefront of epigenetics research, we bring a unique understanding of the field’s toughest challenges and the solutions to overcome them. Our partnerships span academia, industry, and clinical trials, driving innovation from the lab bench to real-world applications. We love pushing the boundaries of epigenetics and are constantly contributing to move the field forward. Researchers worldwide are leveraging our products and services to accelerate discoveries, and our co-authored publications showcase the impact of these collaborations.
See how our shared passion is shaping the future of epigenetics—explore our latest co-authored publications today!
Featured Technologies
EpiCypher is dedicated to creating novel platforms that support innovative chromatin research. We are constantly expanding our product lines to provide the latest in quantitative chromatin technology.
Our Thoughts
Check in for the latest in EpiCypher technology, chromatin research, and conference news!
- Tessa M. Firestone
Interrupting the epigenetic programs that drive tumor growth is a promising avenue for cancer therapy, and NSD2 is emerging as...
- Nathan Hall
CUT&RUN and CUT&Tag have become gold-standard methods for profiling protein–DNA interactions, offering high resolution, low background, and efficient sequencing. While...
- Janna Badalian
Durham, NC – Oct. 16, 2025 (The Scientist) – Winning a spot in the 2025 Top Innovations contest’s Lab Research...



